Sanborn, Rachel E <br/><br/>
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer.  [electronic resource] 

 -  Journal for immunotherapy of cancer  Dec 2017 
 - 103 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-017-0306-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Autophagosomes--transplantation<br/>Cancer Vaccines--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Combined Modality Therapy<br/>Docetaxel<br/>Drug Administration Schedule<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Injections, Intradermal<br/>Interferon-gamma--metabolism<br/>Interleukin-10--metabolism<br/>Interleukin-5--metabolism<br/>Lung Neoplasms--immunology<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Pilot Projects<br/>Pleural Effusion, Malignant--cytology<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--metabolism